FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Uwe Haberkorn

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Rats
Mouse

Concepts & Ideas

Disorders

Anatomy

Co-author Network

Publications

TOP 3
A Afshar-Oromieh; M Eder; Michael Eisenhut; Frederik Giesel; Uwe Haberkorn; Boris A Hadaschik; Sabine Haufe; T Holland-Letz; Clemens Kratochwil; H G Linhart; A Malcher; Christian M Zechmann
Reply to Reske et al.: PET imaging with a [(68)Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Matthias Eder; Michael Eisenhut; John Babich; Uwe Haberkorn
PSMA as a target for radiolabelled small molecules.
A Afshar-Oromieh; M Eder; Michael Eisenhut; Frederik Giesel; Uwe Haberkorn; Boris A Hadaschik; Sabine Haufe; T Holland-Letz; Clemens Kratochwil; H G Linhart; A Malcher; Christian M Zechmann
Erratum to: PET imaging with a [(68)Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Uwe Haberkorn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Afshar-Oromieh; M Eder; Michael Eisenhut; Frederik Giesel; Uwe Haberkorn; Boris A Hadaschik; Sabine Haufe; T Holland-Letz; Clemens Kratochwil; H G Linhart; A Malcher; Christian M Zechmann
Reply to Reske et al.: PET imaging with a [(68)Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
European journal of nuclear medicine and molecular imaging 2013;40(6):971-2.
2013: Matthias Eder; Michael Eisenhut; John Babich; Uwe Haberkorn
PSMA as a target for radiolabelled small molecules.
European journal of nuclear medicine and molecular imaging 2013;40(6):819-23.
2013: A Afshar-Oromieh; M Eder; Michael Eisenhut; Frederik Giesel; Uwe Haberkorn; Boris A Hadaschik; Sabine Haufe; T Holland-Letz; Clemens Kratochwil; H G Linhart; A Malcher; Christian M Zechmann
Erratum to: PET imaging with a [(68)Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
European journal of nuclear medicine and molecular imaging 2013;40(5):797-8.
2013: Walter Mier; Ursula Schierbaum; Martina Schnölzer; Sabine Zitzmann; Annette Altmann; Michael Eisenhut; Susanne Krämer; Karin Leotta; Uwe Haberkorn
PEGylation enables the specific tumor accumulation of a peptide identified by phage display.
Organic & biomolecular chemistry 2013;11(16):2706-11.
2013: Arnt V Kristen; Peter Lohse; Christoph Röcken; Philipp A Schnabel; Stefan O Schonland; Klaus Altland; Thomas J Dengler; Uwe Haberkorn; Stefan E Hardt; Sabine Haufe; Ute Hegenbart; Anthony D Ho; Hugo A Katus
Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis.
International journal of cardiology 2013;164(2):179-84.
2013: Stephanie E Combs; Jan-Oliver Dittmar; Uwe Haberkorn; Daniel Habermehl; Oliver Jäkel; Kerstin Kessel; Stefan Rieken; Thomas Welzel; Jürgen Debus
Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
Acta oncologica (Stockholm, Sweden) 2013;52(3):514-20.
2013: A Afshar-Oromieh; M Eder; Michael Eisenhut; Frederik Giesel; Uwe Haberkorn; Boris A Hadaschik; Sabine Haufe; T Holland-Letz; Clemens Kratochwil; H G Linhart; A Malcher; Christian M Zechmann
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
European journal of nuclear medicine and molecular imaging 2013;40(4):486-95.
2013: Vasileios Askoxylakis; Jürgen Debus; Annette Altmann; Peter E Huber; Annette Markert; Annabell Marr; Walter Mier; Uwe Haberkorn
Peptide-based targeting of the platelet-derived growth factor receptor beta.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2013;15(2):212-21.
2013: Marc-André Weber; Karen Bender; Katharina Grünberg; Uwe Haberkorn; Hans-Ulrich Kauczor; Katja Ott; Annika Stange; Carl Christian von Gall; Christian Zechmann
Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
Journal of gastrointestinal and liver diseases : JGLD 2013;22(1):45-52.
2013: Stefan Delorme; Christian M Zechmann; Uwe Haberkorn
[Imaging diagnostics of hyperparathyroidism].
Der Radiologe 2013;53(3):261-76.
2013: Mazen Jamous; Uwe Haberkorn; Walter Mier
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases.
Molecules (Basel, Switzerland) 2013;18(3):3379-409.
2012: Frederic Zoller; Annette Altmann; Vasileios Askoxylakis; Philippe Barthe; Annette Markert; Walter Mier; Wilko Weichert; Wenye Zhao; Uwe Haberkorn
Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteins.
Angewandte Chemie (International ed. in English) 2012;51(52):13136-9.
2012: Annette Altmann; Vasileios Askoxylakis; Michael Eisenhut; Ralf Jesenofsky; Annette Markert; Tilman Schöning; Uwe Haberkorn
Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(11):1764-71.
2012: Marc S Raab; Mads H Rønnest; Ludmila Weiz; Thomas O Larsen; Blanka Leber; Walter Mier; Felix Nissen; Klaus Podar; Simon Anderhub; Kenneth C Anderson; Iris Breitkreutz; Mads H Clausen; Johannes Fruehauf; Hartmut Goldschmidt; Uwe Haberkorn; Patrick J Hayden; Anthony D Ho; Gleb Konotop; Alwin Krämer
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo.
Cancer research 2012;72(20):5374-85.
2012: Arnt V Kristen; Stephanie Lehrke; Reinhold P Linke; Derliz Mereles; Christoph Röcken; Philipp A Schnabel; Rupert Schreiner; Henning Steen; Erich E Wanker; Klaus Altland; Sebastian J Buss; Thomas J Dengler; Philipp Ehlermann; Evangelos Giannitsis; Uwe Haberkorn; Stefan Hardt; Hugo A Katus
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.
Clinical research in cardiology : official journal of the German Cardiac Society 2012;101(10):805-13.
2012: Frederik Giesel; Uwe Haberkorn; Hans-Ulrich Kauczor; Clemens Kratochwil; A Mehndiratta; J H Moltz; S Wulfert; Christian M Zechmann; Sebastian Ley
Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
European journal of radiology 2012;81(10):2820-5.
2012: Ali Afshar-Oromieh; Stephanie E Combs; Michael Eisenhut; Frederik Giesel; Uwe Haberkorn; Sabine Haufe; Heinz G Linhart; Dino Podlesek; Clemens Kratochwil
Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
European journal of nuclear medicine and molecular imaging 2012;39(9):1409-15.
2012: Sandra Breyer; Simon Geissler; Uwe Haberkorn; Alexandra Hill; Tobias Miller; Angelika Semmler; Walter Mier
Radioiodinated dechloro-4-iodofenofibrate: a hydrophobic model drug for molecular imaging studies.
International journal of pharmaceutics 2012;431(1-2):78-83.
2012: A Afshar-Oromieh; M Eder; Michael Eisenhut; Uwe Haberkorn; C M Zechmann
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.
European journal of nuclear medicine and molecular imaging 2012;39(6):1085-6.
2012: Matthias Eder; Ulrike Bauder-Wüst; Uwe Haberkorn; William-Edmund Hull; Walter Mier; Martin Schäfer; Carmen Wängler; Michael Eisenhut
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
Bioconjugate chemistry 2012;23(4):688-97.
2012: A Afshar-Oromieh; Uwe Haberkorn; Clemens Kratochwil; Frederik Giesel
[Importance of PET/CT in lymphoma diagnostics].
Der Radiologe 2012;52(4):338-46.
2012: Vasileios Askoxylakis; Jürgen Debus; Volker Ehemann; Susanne Krämer; Nuh N Rahbari; Shoaib Rana; Uwe Haberkorn
Binding of the Phage Display Derived Peptide CaIX-P1 on Human Colorectal Carcinoma Cells Correlates with the Expression of Carbonic Anhydrase IX.
International journal of molecular sciences 2012;13(10):13030-48.
2012: Vasileios Askoxylakis; Marc Bischof; Jürgen Debus; Antonia Dimitrakopoulou-Strauss; Julien Dinkel; Monika Eichinger; Uwe Haberkorn; Peter E Huber; Annette Kopp-Schneider; Gregor Sommer; Bram Stieltjes; Ludwig G Strauss; Christian Thieke
Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial.
Radiation oncology (London, England) 2012;7():157.
2012: Shoaib Rana; Annette Altmann; Juergen Debus; Uwe Haberkorn; Annette Markert; Annabell Marr; Walter Mier; Felix Nissen; Vasileios Askoxylakis
Optimization of a novel peptide ligand targeting human carbonic anhydrase IX.
PloS one 2012;7(5):e38279.
2012: Martin Schäfer; Frederic Zoller; Ulrike Bauder-Wüst; Michael Eisenhut; Uwe Haberkorn; Karin Leotta; Walter Mier; Matthias Eder
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer.
EJNMMI research 2012;2(1):23.
2012: Markus Thiemann; Klaus-Josef Weber; Wilko Weichert; Marc Bischof; Jürgen Debus; Volker Ehemann; Uwe Haberkorn; Peter E Huber; Andreas E Kulozik; Susanne Oertel; Ramon Lopez Perez; Albrecht Stenzinger; Claudia Battmann
In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
Radiation oncology (London, England) 2012;7():52.
2012: Frederik Giesel; Uwe Haberkorn; F Bergmann; M P Mafomane; A Mehndiratta; P Schemmer; Christian M Zechmann; Clemens Kratochwil
Cancer with unknown primary: finding a needle in a hay stack.
Experimental oncology 2012;34(1):64-5.
2012: Anne Katrin Berger; Stefan Delorme; Georg Martin Haag; Uwe Haberkorn; Matthias Kloor; Florian Lordick; Jennifer Ose; Annika Stange; Carl von Gall; Tim Frederik Weber; Ulrich Abel; Dirk Jäger
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial.
BMC cancer 2012;12():108.
2012: Mustafa Takesh; Uwe Haberkorn; Safwan Roumia; Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss
Incidental detection and monitoring of spontaneous recovery of sarcoidosis via fluorine-18-fluoroethyl-choline positron emission tomography/computed tomography.
Hellenic journal of nuclear medicine 2012;15(1):63-5.
2011: Ludwig G. Strauss; Stefan Willis; Caixia Cheng; Uwe Haberkorn; Sven Klippel; Dirk Koczan; Leyun Pan; Antonia Dimitrakopoulou-Strauss
Impact of cell-proliferation-associated gene expression on 2-deoxy-2-[(18)f]fluoro-D-glucose (FDG) kinetics as measured by dynamic positron emission tomography (dPET) in colorectal tumors.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(6):1290-300.
2011: Uwe Haberkorn; A Markert; Walter Mier; Vasileios Askoxylakis; Annette Altmann
Molecular imaging of tumor metabolism and apoptosis.
Oncogene 2011;30(40):4141-51.
2011: Clemens Kratochwil; Ruben López-Benítez; Walter Mier; Peter L Choyke; Uwe Haberkorn; Sabine Haufe; Berend Isermann; Hans-Ulrich Kauczor; Frederik L Giesel
Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases.
Endocrine-related cancer 2011;18(5):595-602.
2011: Sandra Purz; Jochen Rössler; Kathrin Ruschke; Osama Sabri; Otmar Schober; Ina Sorge; Martina Stiefel; Wolfgang A Weber; Holger Amthauer; Martina Becker; Karoline Ehlert; Uwe Haberkorn; Dirk Hasenclever; Patrick Hundsdörfer; Dieter Körholz; W Tilman Kranert; Antje Krausse; Andreas E Kulozik; Christine Mauz-Körholz; Regine Kluge
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(26):3523-8.
2011: Alexandra D Jensen; Marc W Münter; Michael Thomas; Peter E Huber; Helge G Bischoff; Jürgen Debus; Uwe Haberkorn; Renate Haselmann; Klaus K Herfarth
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial.
Cancer 2011;117(13):2986-94.
2011: Ludwig G. Strauss; Leyun Pan; Caixia Cheng; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(3):379-85.
2011: Antonia Dimitrakopoulou-Strauss; Marcel Seiz; Jochen Tuettenberg; Kirsten Schmieder; Michael Eisenhut; Uwe Haberkorn; Ludwig G. Strauss
Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results.
Clinical nuclear medicine 2011;36(2):101-8.
2011: Julia Duerr; Maren Gruner; Susanne C Schubert; Uwe Haberkorn; Hermann Bujard; Marcus Mall
Use of a new-generation reverse tetracycline transactivator system for quantitative control of conditional gene expression in the murine lung.
American journal of respiratory cell and molecular biology 2011;44(2):244-54.
2011: Caixia Cheng; Antonia Dimitrakopoulou-Strauss; Uwe Haberkorn; Leyun Pan; Martin Schäfer; Björn Wängler; Carmen Wängler; Ludwig G. Strauss
Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line.
EJNMMI research 2011;1():34.
2011: Sylvie Lorenzen; Ulrich Abel; Jürgen Debus; Georg M Haag; Uwe Haberkorn; Dirk Jäger; Florian Lordick; Annika Stange; Carl von Gall; Wilko Weichert; Jürgen Weitz; Marc W Münter
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
BMC cancer 2011;11():266.
2011: Vasileios Askoxylakis; Gunda Millonig; Ute Wirkner; Christian Schwager; Shoaib Rana; Annette Altmann; Uwe Haberkorn; Jürgen Debus; Sebastian Mueller; Peter E Huber
Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency.
Radiation oncology (London, England) 2011;6():35.
2011: Frederic Zoller; Uwe Haberkorn; Walter Mier
Miniproteins as phage display-scaffolds for clinical applications.
Molecules (Basel, Switzerland) 2011;16(3):2467-85.
2011: Thomas Lindner; Harald Kolmar; Uwe Haberkorn; Walter Mier
DNA libraries for the construction of phage libraries: statistical and structural requirements and synthetic methods.
Molecules (Basel, Switzerland) 2011;16(2):1625-41.
2011: Vasileios Askoxylakis; Sabine Zitzmann-Kolbe; Frederic Zoller; Annette Altmann; Annette Markert; Shoaib Rana; Annabell Marr; Walter Mier; Jürgen Debus; Uwe Haberkorn
Challenges in optimizing a prostate carcinoma binding peptide, identified through the phage display technology.
Molecules (Basel, Switzerland) 2011;16(2):1559-78.
2010: Dikran Sarko; Barbro Beijer; Regine Garcia Boy; Eva-Maria Nothelfer; Karin Leotta; Michael Eisenhut; Annette Altmann; Uwe Haberkorn; Walter Mier
The pharmacokinetics of cell-penetrating peptides.
Molecular pharmaceutics 2010;7(6):2224-31.
2010: Annette Altmann; Michael Eisenhut; Ulrike Bauder-Wüst; Annette Markert; Vasileios Askoxylakis; Holger Hess-Stumpp; Uwe Haberkorn
Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275.
European journal of nuclear medicine and molecular imaging 2010;37(12):2286-97.
2010: Holger Kubas; Martin Schäfer; Ulrike Bauder-Wüst; Matthias Eder; Dörte Oltmanns; Uwe Haberkorn; Walter Mier; Michael Eisenhut
Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.
Nuclear medicine and biology 2010;37(8):885-91.
2010: C Kratochwil; Uwe Haberkorn; F L Giesel
[PET/CT for diagnostics and therapy stratification of lung cancer].
Der Radiologe 2010;50(8):684-91.
2010: Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Gerlinde Egerer; Julie Vasamiliette; Thomas Schmitt; Uwe Haberkorn; Bernd Kasper
Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis.
European journal of nuclear medicine and molecular imaging 2010;37(8):1481-9.
2010: Regine García Boy; Walter Mier; Eva Maria Nothelfer; Annette Altmann; Michael Eisenhut; Harald Kolmar; Michael Tomaszowski; Susanne Krämer; Uwe Haberkorn
Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(4):377-85.
2010: Alexa Schieck; Thomas Müller; Andreas Schulze; Uwe Haberkorn; Stephan Urban; Walter Mier
Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitor.
Molecules (Basel, Switzerland) 2010;15(7):4773-83.
2010: Matthias Eder; Stefan Knackmuss; Fabrice Le Gall; Uwe Reusch; Vladimir Rybin; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut
68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours.
European journal of nuclear medicine and molecular imaging 2010;37(7):1397-407.
2010: Clemens Kratochwil; Frederik L Giesel; Ruben López-Benítez; Nadine Schimpfky; Kirsten Kunze; Michael Eisenhut; Hans-Ulrich Kauczor; Uwe Haberkorn
Intraindividual comparison of selective arterial versus venous 68Ga-DOTATOC PET/CT in patients with gastroenteropancreatic neuroendocrine tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2899-905.
2010: Matthias Eder; Arcadius V Krivoshein; Marina Backer; Joseph M Backer; Uwe Haberkorn; Michael Eisenhut
ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Nuclear medicine and biology 2010;37(4):405-12.
2010: Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Gerlinde Egerer; Julie Vasamiliette; Gunhild Mechtersheimer; Thomas Schmitt; Burkhard Lehner; Uwe Haberkorn; Philipp Stroebel; Bernd Kasper
Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(4):551-8.
2010: Andreas Behren; York Kamenisch; Sabrina Muehlen; Christa Flechtenmacher; Uwe Haberkorn; Hermann Hilber; Jeffrey N Myers; Zazie Bergmann; Peter Karl Plinkert; Christian Simon
Development of an oral cancer recurrence mouse model after surgical resection.
International journal of oncology 2010;36(4):849-55.
2010: Vasileios Askoxylakis; Regine Garcia-Boy; Shoaib Rana; Susanne Krämer; Ulrike Hebling; Walter Mier; Annette Altmann; Annette Markert; Jürgen Debus; Uwe Haberkorn
A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology.
PloS one 2010;5(12):e15962.
2010: Uwe Haberkorn; V Askoxylakis; A Markert; Annette Altmann
[Iodide enrichment in malignant tumours after gene transfer].
Nuklearmedizin. Nuclear medicine 2010;49 Suppl 1():S21-5.
2009: Frederic Zoller; Michael Eisenhut; Uwe Haberkorn; Walter Mier
Endoradiotherapy in cancer treatment--basic concepts and future trends.
European journal of pharmacology 2009;625(1-3):55-62.
2009: Christof Hofele; Kolja Freier; Oliver C Thiele; Uwe Haberkorn; Inga Buchmann
High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
Oral oncology 2009;45(11):963-7.
2009: Antonia Dimitrakopoulou-Strauss; Martin Hoffmann; Raoul Bergner; Michael Uppenkamp; Uwe Haberkorn; Ludwig G. Strauss
Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.
Clinical nuclear medicine 2009;34(9):576-84.
2009: Ludwig G. Strauss; Johannes Hoffend; Dirk Koczan; Leyun Pan; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics.
European journal of nuclear medicine and molecular imaging 2009;36(8):1226-34.
2009: Sabine Mai; Grit Welzel; Brigitte Hermann; Frederik Wenz; Uwe Haberkorn; Dietmar Dinter
Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(4):254-9.
2009: Eva-Maria Nothelfer; Sabine Zitzmann-Kolbe; Regine Garcia-Boy; Susanne Krämer; Christel Herold-Mende; Annette Altmann; Michael Eisenhut; Walter Mier; Uwe Haberkorn
Identification and characterization of a peptide with affinity to head and neck cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(3):426-34.
2009: Inga Buchmann; Ralf G Meyer; Walter Mier; Uwe Haberkorn
Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?
European journal of nuclear medicine and molecular imaging 2009;36(3):484-98.
2009: D Oltmanns; Michael Eisenhut; Walter Mier; Uwe Haberkorn
Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors.
Current medicinal chemistry 2009;16(17):2086-94.
2008: Volker Rudat; Marc W Münter; Dirk Rades; Knut A Grötz; Amira Bajrovic; Uwe Haberkorn; Winfried Brenner; Jürgen Debus
The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;89(1):71-80.
2008: Matthias Eder; Björn Wängler; Stefan Knackmuss; Fabrice LeGall; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut
Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.
European journal of nuclear medicine and molecular imaging 2008;35(10):1878-86.
2008: Ludwig G. Strauss; Dirk Koczan; Sven Klippel; Leyun Pan; Caixia Cheng; Stefan Willis; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1238-44.
2008: Inga Buchmann; Uwe Haberkorn; Irene Schmidtmann; Christoph Brochhausen; Hans-Georg Buchholz; Peter Bartenstein; Torsten Hansen
Influence of cell proportions and proliferation rates on FDG uptake in squamous-cell esophageal carcinoma: a PET study.
Cancer biotherapy & radiopharmaceuticals 2008;23(2):172-80.
2008: Inga Buchmann; T M Ganten; Uwe Haberkorn
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Zeitschrift für Gastroenterologie 2008;46(4):367-75.
2008: L Krüger; Helmut Eskerski; Christiane Dinsart; Jan J Cornelis; Jean Rommelaere; Uwe Haberkorn; Jürgen A Kleinschmidt
Augmented transgene expression in transformed cells using a parvoviral hybrid vector.
Cancer gene therapy 2008;15(4):252-67.
2008: Bernd Kasper; Sascha Dietrich; Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Uwe Haberkorn; Anthony Ho; Gerlinde Egerer
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Onkologie 2008;31(3):107-12.
2008: Jörg Petersen; Maura Dandri; Walter Mier; Marc Lütgehetmann; Tassilo Volz; Fritz von Weizsäcker; Uwe Haberkorn; Lutz Fischer; Jörg-Matthias Pollok; Berit Erbes; Stefan Seitz; Stephan Urban
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Nature biotechnology 2008;26(3):335-41.
2008: C Wängler; Björn Wängler; Michael Eisenhut; Uwe Haberkorn; Walter Mier
Improved syntheses and applicability of different DOTA building blocks for multiply derivatized scaffolds.
Bioorganic & medicinal chemistry 2008;16(5):2606-16.
2008: Regine Garcia Boy; Eva-Maria Knapp; Michael Eisenhut; Uwe Haberkorn; Walter Mier
Enzymes/transporters.
Handbook of experimental pharmacology 2008;(185 Pt 2):131-43.
2008: Uwe Haberkorn
PET and SPECT.
Handbook of experimental pharmacology 2008;(185 Pt 2):13-35.
2008: Uwe Haberkorn; Michael Eisenhut; Annette Altmann; Walter Mier
Endoradiotherapy with peptides - status and future development.
Current medicinal chemistry 2008;15(3):219-34.
2007: Inga Buchmann; Karen Riedmüller; Simone Hoffner; Ulrich Mack; Sebastian Aulmann; Uwe Haberkorn
Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer.
Cancer biotherapy & radiopharmaceuticals 2007;22(6):779-89.
2007: Arnt V Kristen; Philipp Ehlermann; Burkhard Helmke; Ernst Hund; Uwe Haberkorn; Reinhold P Linke; Hugo A Katus; Pia Winter; Klaus Altland; Thomas J Dengler
Transthyretin valine-94-alanine, a novel variant associated with late-onset systemic amyloidosis with cardiac involvement.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2007;14(4):283-7.
2007: Uwe Haberkorn; Johannes Hoffend; Kerstin Schmidt; Annette Altmann; Gabriel A Bonaterra; Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Michael Eisenhut; Ralf Kinscherf
Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma.
European journal of nuclear medicine and molecular imaging 2007;34(12):2011-23.
2007: Inga Buchmann; Marcus Henze; S Engelbrecht; Michael Eisenhut; A Runz; M Schäfer; T Schilling; Sabine Haufe; T Herrmann; Uwe Haberkorn
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.
European journal of nuclear medicine and molecular imaging 2007;34(10):1617-26.
2007: Walter Mier; Sabine Zitzmann; Susanne Krämer; Jennifer Reed; Eva-Maria Knapp; Annette Altmann; Michael Eisenhut; Uwe Haberkorn
Influence of chelate conjugation on a newly identified tumor-targeting peptide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(9):1545-52.
2007: Antonia Dimitrakopoulou-Strauss; Martin Hoffmann; Raoul Bergner; Michael Uppenkamp; Michael Eisenhut; Leyun Pan; Uwe Haberkorn; Ludwig G. Strauss
Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a feasibility study.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(5):308-17.
2007: Karin Frank-Raue; Michael Fabel; Stefan Delorme; Uwe Haberkorn; Friedhelm Raue
Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma.
European journal of endocrinology / European Federation of Endocrine Societies 2007;157(2):215-20.
2007: Antonia Dimitrakopoulou-Strauss; Peter Hohenberger; Uwe Haberkorn; Helmut R Mäcke; Michael Eisenhut; Ludwig G. Strauss
68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(8):1245-50.
2007: Aoife Hunt; Peter Schönknecht; Marcus Henze; Ulrich Seidl; Uwe Haberkorn; Johannes Schröder
Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
Psychiatry research 2007;155(2):147-54.
2007: Ludwig G. Strauss; Leyun Pan; Dirk Koczan; Sven Klippel; Krzysztof Mikolajczyk; Cyrill Burger; Uwe Haberkorn; Klaus Schönleben; Hans-Jürgen Thiesen; Antonia Dimitrakopoulou-Strauss
Fusion of positron emission tomography (PET) and gene array data: a new approach for the correlative analysis of molecular biological and clinical data.
IEEE transactions on medical imaging 2007;26(6):804-12.
2007: Jochen Utikal; Selma Ugurel; Hjalmar Kurzen; Philipp Erben; Andreas Reiter; Andreas Hochhaus; Thomas Nebe; Ralf Hildenbrand; Uwe Haberkorn; Sergij Goerdt; Dirk Schadendorf
Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.
Archives of dermatology 2007;143(6):736-40.
2007: Sabine Zitzmann; Susanne Krämer; Walter Mier; Ulrike Hebling; Annette Altmann; Axel Rother; Dietmar Berndorff; Michael Eisenhut; Uwe Haberkorn
Identification and evaluation of a new tumor cell-binding peptide, FROP-1.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(6):965-72.
2007: Ludwig G. Strauss; Sven Klippel; Leyun Pan; Klaus Schönleben; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
European journal of nuclear medicine and molecular imaging 2007;34(6):868-77.
2007: Bernd Kasper; Gerlinde Egerer; Martina Gronkowski; Sabine Haufe; Thomas Lehnert; Michael Eisenhut; Gunhild Mechtersheimer; Anthony Ho; Uwe Haberkorn
Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET.
Leukemia & lymphoma 2007;48(4):746-53.
2007: Marc W Münter; Simone Hoffner; Holger Hof; Klaus K Herfarth; Uwe Haberkorn; Volker Rudat; Peter Huber; Jürgen Debus; Christian P Karger
Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
International journal of radiation oncology, biology, physics 2007;67(3):651-9.
2007: Markus Wolf; William E Hull; Walter Mier; Sabine Heiland; Ulrike Bauder-Wüst; Ralf Kinscherf; Uwe Haberkorn; Michael Eisenhut
Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.
Journal of medicinal chemistry 2007;50(1):139-48.
2007: Keith Graham; Qin Wang; Regine Garcia Boy; Michael Eisenhut; Uwe Haberkorn; Walter Mier
Synthesis and evaluation of intercalating somatostatin receptor binding peptide conjugates for endoradiotherapy.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2007;10(2):286s-297s.
2007: Carmen Wängler; Inga Buchmann; Michael Eisenhut; Uwe Haberkorn; Walter Mier
Radiolabeled peptides and proteins in cancer therapy.
Protein and peptide letters 2007;14(3):273-9.
2006: Markus Wolf; Helmut Eskerski; Ulrike Bauder-Wüst; Uwe Haberkorn; Michael Eisenhut
Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.
Melanoma research 2006;16(6):487-96.
2006: Sophia Koukouraki; Ludwig G. Strauss; Vassilis Georgoulias; Michael Eisenhut; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
European journal of nuclear medicine and molecular imaging 2006;33(10):1115-22.
2006: Pierre Kunz; Johannes Hoffend; Annette Altmann; Antonia Dimitrakopoulou-Strauss; Dirk Koczan; Michael Eisenhut; Gabriel A Bonaterra; Thomas J Dengler; Walter Mier; Uwe Haberkorn; Ralf Kinscherf
Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1515-24.
2006: Kerstin Schmidt; Johannes Hoffend; Annette Altmann; Fabian Kiessling; Ludwig G. Strauss; Dirk Koczan; Walter Mier; Michael Eisenhut; Ralf Kinscherf; Uwe Haberkorn
Troponin I overexpression inhibits tumor growth, perfusion, and vascularization of morris hepatoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1506-14.
2006: Michael Eisenhut; Uwe Haberkorn
Molecular position of radiolabels and its impact on functional integrity of proteins.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1400-2.
2006: Antonia Dimitrakopoulou-Strauss; Marion Wilmsmeyer; Stephan König; Susanne Schubert; K Wolfgang Neff; Uwe Haberkorn; Ludwig G. Strauss
18F-FDG PET in a 10-year-old female patient with subacute sclerosing panencephalitis.
European journal of nuclear medicine and molecular imaging 2006;33(9):1100-1.
2006: Antonia Dimitrakopoulou-Strauss; Vassilis Georgoulias; Michael Eisenhut; Felix Herth; Sophia Koukouraki; Helmut R Mäcke; Uwe Haberkorn; Ludwig G. Strauss
Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.
European journal of nuclear medicine and molecular imaging 2006;33(7):823-30.
2006: Vasileios Askoxylakis; Walter Mier; Sabine Zitzmann; Volker Ehemann; Jianbing Zhang; Susanne Krämer; Carmen Beck; Manfred Schwab; Michael Eisenhut; Uwe Haberkorn
Characterization and development of a peptide (p160) with affinity for neuroblastoma cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):981-8.
2006: Libo Chen; Annette Altman; Walter Mier; Hankui Lu; Ruisen Zhu; Uwe Haberkorn
99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression.
Nuclear medicine and biology 2006;33(4):575-80.
2006: Libo Chen; Annette Altmann; Walter Mier; Helmut Eskerski; Karin Leotta; Lihe Guo; Ruisen Zhu; Uwe Haberkorn
Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):854-62.
2006: Stefanie Milker-Zabel; Angelika Zabel-du Bois; Marcus Henze; Peter Huber; Daniela Schulz-Ertner; Angelika Hoess; Uwe Haberkorn; Jürgen Debus
Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
International journal of radiation oncology, biology, physics 2006;65(1):222-7.
2006: Osmar Calderon Sanchez; Ashour Mohammed; Claudia Bauer; Markus Wolf; Björn Wängler; Walter Mier; Uwe Haberkorn; Raoul Mocelo; Michael Eisenhut
(99m)Tc complexes with activated ester functions; ligands comprising a 3,4-diamino-benzoate backbone.
Nuclear medicine and biology 2006;33(3):381-90.
2006: Sophia Koukouraki; Ludwig G. Strauss; Vassilis Georgoulias; Jochen Schuhmacher; Uwe Haberkorn; Nikolaos Karkavitsas; Antonia Dimitrakopoulou-Strauss
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
European journal of nuclear medicine and molecular imaging 2006;33(4):460-6.
2006: Kerstin Schmidt; Johannes Hoffend; Annette Altmann; Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss; Britta Engelhardt; Dirk Koczan; Jörg Peter; Thomas J Dengler; Walter Mier; Michael Eisenhut; Uwe Haberkorn; Ralf Kinscherf
Angiostatin overexpression in Morris hepatoma results in decreased tumor growth but increased perfusion and vascularization.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):543-51.
2006: Alexandra D Jensen; Marc W Münter; H Bischoff; R Haselmann; Carmen Timke; Robert Krempien; Florian Sterzing; Simeon Nill; Steffen Heeger; Angelika Hoess; Uwe Haberkorn; Peter E Huber; Martin B Steins; Michael Thomas; Jürgen Debus; Klaus K Herfarth
Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518).
BMC cancer 2006;6():122.
2006: Sabine E Haufe; K Riedmüller; Uwe Haberkorn
Nuclear medicine procedures for the diagnosis of acute and chronic renal failure.
Nephron. Clinical practice 2006;103(2):c77-84.
2006: Marcus Henze; N Ozdemir-Sahin; Peter Hipp; Walter Mier; M Eisenhut; Jürgen Debus; Uwe Haberkorn
[Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
Nuklearmedizin. Nuclear medicine 2006;45(1):49-56.
2005: Martin Krause; Stefan Hähnel; Uwe Haberkorn; Hans-Michael Meinck
Dopa-responsive hemiparkinsonism due to midbrain Virchow-Robin spaces?
Journal of neurology 2005;252(12):1555-7.
2005: Iván Peñuelas; Uwe Haberkorn; Shahriar Yaghoubi; Sanjiv S Gambhir
Gene therapy imaging in patients for oncological applications.
European journal of nuclear medicine and molecular imaging 2005;32 Suppl 2():S384-403.
2005: Uwe Haberkorn; Michael Eisenhut
Molecular imaging and therapy -- a programme based on the development of new biomolecules.
European journal of nuclear medicine and molecular imaging 2005;32(12):1354-9.
2005: Markus Wolf; Ulrike Bauder-Wüst; Uwe Haberkorn; Walter Mier; Michael Eisenhut
Alkylating benzamides with melanoma cytotoxicity: role of melanin, tyrosinase, intracellular pH and DNA interaction.
Melanoma research 2005;15(5):383-91.
2005: Vasileios Askoxylakis; Sabine Zitzmann; Walter Mier; Keith Graham; Susanne Krämer; Frederic von Wegner; Rainer H A Fink; Manfred Schwab; Michael Eisenhut; Uwe Haberkorn
Preclinical evaluation of the breast cancer cell-binding peptide, p160.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6705-12.
2005: Claudia Bauer; Ulrike Bauder-Wuest; Walter Mier; Uwe Haberkorn; Michael Eisenhut
131I-labeled peptides as caspase substrates for apoptosis imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1066-74.
2005: Annette Altmann; Ralf B Schulz; Gabriela Glensch; Helmut Eskerski; Sabine Zitzmann; Michael Eisenhut; Uwe Haberkorn
Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):831-9.
2005: Sabine Zitzmann; Susanne Krämer; Walter Mier; Miriam Mahmut; Julian Fleig; Annette Altmann; Michael Eisenhut; Uwe Haberkorn
Identification of a new prostate-specific cyclic peptide with the bacterial FliTrx system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):782-5.
2005: Marcus Henze; Antonia Dimitrakopoulou-Strauss; Stefanie Milker-Zabel; Jochen Schuhmacher; Ludwig G. Strauss; Josef Doll; Helmut R Mäcke; Michael Eisenhut; Jürgen Debus; Uwe Haberkorn
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):763-9.
2005: Johannes Hoffend; Walter Mier; Jochen Schuhmacher; Kerstin Schmidt; Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Michael Eisenhut; Ralf Kinscherf; Uwe Haberkorn
Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo.
Nuclear medicine and biology 2005;32(3):287-92.
2005: Jochen Schuhmacher; Hanwen Zhang; Josef Doll; Helmut R Mäcke; Ronald Matys; Harald Hauser; Marcus Henze; Uwe Haberkorn; Michael Eisenhut
GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(4):691-9.
2005: Kerstin Schmidt; Johannes Hoffend; Annette Altmann; Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss; Britta Engelhardt; Dirk Koczan; Jörg Peter; Silke Vorwald; Helmut Eskerski; Michael Eisenhut; Jürgen Metz; Ralf Kinscherf; Uwe Haberkorn
Transfer of the sFLT-1 gene in Morris hepatoma results in decreased growth and perfusion and induction of genes associated with stress response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2132-40.
2005: J Ludwig; Gunhild Mechtersheimer; Uwe Haberkorn; Peter Nawroth; Tobias Schilling; Christian Kasperk
[Oncogenic osteomalacia in a 49-year-old female patient].
Deutsche medizinische Wochenschrift (1946) 2005;130(5):206-9.
2005: Uwe Haberkorn
Modulation of tracer accumulation in malignant tumors: gene expression, gene transfer, and phage display.
Current topics in developmental biology 2005;70():145-69.
2005: Uwe Haberkorn; Walter Mier; Michael Eisenhut
Scintigraphic imaging of gene expression and gene transfer.
Current medicinal chemistry 2005;12(7):779-94.
2005: Sabine Zitzmann; Walter Mier; Arno Schad; Ralf Kinscherf; Vasileios Askoxylakis; Susanne Krämer; Annette Altmann; Michael Eisenhut; Uwe Haberkorn
A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):139-46.
2005: Walter Mier; Johannes Hoffend; Susanne Krämer; Jochen Schuhmacher; William E Hull; Michael Eisenhut; Uwe Haberkorn
Conjugation of DOTA using isolated phenolic active esters: the labeling and biodistribution of albumin as blood pool marker.
Bioconjugate chemistry 2005;16(1):237-40.
2005: Helmut R Maecke; Michael Hofmann; Uwe Haberkorn
(68)Ga-labeled peptides in tumor imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():172S-8S.
2004: Markus Wolf; Ulrike Bauder-Wüst; Ashour Mohammed; Frank Schönsiegel; Walter Mier; Uwe Haberkorn; Michael Eisenhut
Alkylating benzamides with melanoma cytotoxicity.
Melanoma research 2004;14(5):353-60.
2004: Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss; Dirk Koczan; Ludger Bernd; Uwe Haberkorn; Volker Ewerbeck; Hans-Jürgen Thiesen
18F-FDG kinetics and gene expression in giant cell tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(9):1528-35.
2004: Grigorios Korosoglou; Alexander Hansen; Johannes Hoffend; Goran Gavrilovic; David Gregor Wolf; Joerg Zehelein; Uwe Haberkorn; Helmut Kuecherer
Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron emission tomography and dobutamine stress echocardiography.
The American journal of cardiology 2004;94(5):570-6.
2004: Uwe Haberkorn
Positron emission tomography in the diagnosis of mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2004;45 Suppl 1():S73-6.
2004: Josef Doll; Marcus Henze; O Bublitz; A Werling; Lars-Eric Adam; Uwe Haberkorn; W Semmler; Gunnar Brix
[High resolution reconstruction of PET images using the iterative OSEM algorithm].
Nuklearmedizin. Nuclear medicine 2004;43(3):72-8.
2004: Frank Schoensiegel; Annette Paschen; Stephanie Sieger; Helmut Eskerski; Walter Mier; Heike Rothfels; Jürgen A Kleinschmidt; Dirk Schadendorf; Uwe Haberkorn
MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
Cancer gene therapy 2004;11(6):408-18.
2004: Uwe Haberkorn; Petra Beuter; Wolfgang Kübler; Helmut Eskerski; Michael Eisenhut; Ralf Kinscherf; Sabine Zitzmann; Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss; Annette Altmann
Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(5):827-33.
2004: Marcus Henze; Ashour Mohammed; Heinz-Peter Schlemmer; Klaus K Herfarth; Simone Hoffner; Sabine Haufe; Walter Mier; Michael Eisenhut; Jürgen Debus; Uwe Haberkorn
PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):579-86.
2004: Marcus Henze; Jochen Schuhmacher; Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Helmut R Mäcke; Michael Eisenhut; Uwe Haberkorn
Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.
European journal of nuclear medicine and molecular imaging 2004;31(3):466.
2004: Qin Wang; Keith Graham; Thomas Schauer; Thomas Fietz; Ashour Mohammed; Xiuxin Liu; Johannes Hoffend; Uwe Haberkorn; Michael Eisenhut; Walter Mier
Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate.
Nuclear medicine and biology 2004;31(1):21-30.
2004: Uwe Haberkorn; Annette Altmann; Walter Mier; Michael Eisenhut
Impact of functional genomics and proteomics on radionuclide imaging.
Seminars in nuclear medicine 2004;34(1):4-22.
2004: Stephanie Sieger; Shiming Jiang; Jürgen A Kleinschmidt; Helmut Eskerski; Frank Schönsiegel; Annette Altmann; Walter Mier; Uwe Haberkorn
Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene.
Cancer gene therapy 2004;11(1):41-51.
2003: Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss; Uwe Haberkorn
Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(12):1933-9.
2003: O Calderon Sanchez; Ashour Mohammed; Walter Mier; Keith Graham; Jochen Schuhmacher; S O Arndt; Uwe Haberkorn; R Mocelo; Michael Eisenhut
2,3,5,6-Tetrafluorophenyl N-(S-benzoylthioacetyl)glycylglycyl- p-aminobenzoate, a heterobifunctional (99m)Tc ligand for precomplexed antibody labeling.
Bioconjugate chemistry 2003;14(6):1209-13.
2003: Peter Schönknecht; Marcus Henze; Aoife Hunt; Klaus Klinga; Uwe Haberkorn; Johannes Schröder
Hippocampal glucose metabolism is associated with cerebrospinal fluid estrogen levels in postmenopausal women with Alzheimer's disease.
Psychiatry research 2003;124(2):125-7.
2003: Annette Altmann; Maria Kissel; Sabine Zitzmann; Wolfgang Kübler; Miriam Mahmut; Peter Peschke; Uwe Haberkorn
Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(6):973-80.
2003: Uwe Haberkorn; Annette Altmann
Noninvasive imaging of protein-protein interactions in living organisms.
Trends in biotechnology 2003;21(6):241-3.
2003: Uwe Haberkorn; Ralf Kinscherf; Maria Kissel; Wolfgang Kübler; Miriam Mahmut; Stephanie Sieger; Michael Eisenhut; Peter Peschke; Annette Altmann
Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
Gene therapy 2003;10(9):774-80.
2003: Stephanie Sieger; Shiming Jiang; Frank Schönsiegel; Helmut Eskerski; Wolfgang Kübler; Annette Altmann; Uwe Haberkorn
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
European journal of nuclear medicine and molecular imaging 2003;30(5):748-56.
2003: Walter Mier; Ramon Eritja; Ashour Mohammed; Uwe Haberkorn; Michael Eisenhut
Peptide-PNA conjugates: targeted transport of antisense therapeutics into tumors.
Angewandte Chemie (International ed. in English) 2003;42(17):1968-71.
2003: Michaela Angelescu; Thomas W Kraus; Manfred Wiesel; Olaf Hergesell; Uwe Haberkorn; Ernst Klar
Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation.
Transplantation 2003;75(8):1190-6.
2003: Johannes Hoffend; G Linke; Ashour Mohammed; Christiane Tiefenbacher; Michael Eisenhut; Uwe Haberkorn
99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.
European journal of nuclear medicine and molecular imaging 2003;30(4):494-501.
2003: Uwe Haberkorn; Annette Altmann
Functional genomics and radioisotope-based imaging procedures.
Annals of medicine 2003;35(6):370-9.
2003: Jörg Kowalski; Marcus Henze; Jochen Schuhmacher; Helmut R Mäcke; Michael Hofmann; Uwe Haberkorn
Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2003;5(1):42-8.
2002: Michael Eisenhut; Ashour Mohammed; Walter Mier; Frank Schönsiegel; Matthias Friebe; Ashfaq Mahmood; Alun G Jones; Uwe Haberkorn
Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural element.
Journal of medicinal chemistry 2002;45(26):5802-5.
2002: Marcus Henze; Ashour Mohammed; Heinz-Peter Schlemmer; Klaus K Herfarth; Walter Mier; Michael Eisenhut; Jürgen Debus; Uwe Haberkorn
Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
European journal of nuclear medicine and molecular imaging 2002;29(11):1455-61.
2002: Alexander Gutschalk; Rainer Kollmar; Alexander Mohr; Marcus Henze; Nicole Ille; Markus Schwaninger; Marius Hartmann; Stefan Hähnel; Uwe Haberkorn; André Rupp; Uta Meyding-Lamade
Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine.
Neuroscience letters 2002;332(2):115-8.
2002: Marcus Henze; Ashour Mohammed; Walter Mier; Volker Rudat; Andreas Dietz; Jörg Nollert; Michael Eisenhut; Uwe Haberkorn
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
European journal of nuclear medicine and molecular imaging 2002;29(3):324-30.
2002: S J Martin; J A Eisenbarth; U Wagner-Utermann; Walter Mier; Marcus Henze; H Pritzkow; Uwe Haberkorn; Michael Eisenhut
A new precursor for the radiosynthesis of [18F]FLT.
Nuclear medicine and biology 2002;29(2):263-73.
2002: Uwe Haberkorn; Annette Altmann
Radionuclide imaging in the post-genomic era.
Journal of cellular biochemistry. Supplement 2002;39():1-10.
2002: Uwe Haberkorn; Annette Altmann; Michael Eisenhut
Functional genomics and proteomics--the role of nuclear medicine.
European journal of nuclear medicine and molecular imaging 2002;29(1):115-32.
2001: Stefan Delorme; Uwe Haberkorn; Ralf Kinscherf; Ivan Zuna; Malte L Bahner; Gerhard van Kaick
Changes of tumor vascularity during gene therapy monitored with color Doppler US.
Ultrasound in medicine & biology 2001;27(12):1595-603.
2001: Uwe Haberkorn; S O Schoenberg
Imaging of lung cancer with CT, MRT and PET.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 3():S13-23.
2001: Uwe Haberkorn
Positron emission tomography (PET) of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 2():S115-21.
2001: Uwe Haberkorn; Annette Altmann; Huse Kamencic; I Morr; U Traut; Marcus Henze; Shiming Jiang; Jürgen Metz; Ralf Kinscherf
Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.
European journal of nuclear medicine 2001;28(11):1690-6.
2001: Uwe Haberkorn; Ralf Kinscherf; Peter H Krammer; Walter Mier; Michael Eisenhut
Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone.
Nuclear medicine and biology 2001;28(7):793-8.
2001: Gunnar Brix; S I Ziegler; Matthias E Bellemann; Josef Doll; R Schosser; Robert Lucht; H Krieter; D Nosske; Uwe Haberkorn
Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(8):1265-73.
2001: Uwe Haberkorn; Annette Altmann
Imaging methods in gene therapy of cancer.
Current gene therapy 2001;1(2):163-82.
2001: Shiming Jiang; Annette Altmann; D Grimm; Jürgen A Kleinschmidt; T Schilling; C Germann; Uwe Haberkorn
Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectors.
Cancer gene therapy 2001;8(7):469-72.
2001: Marcus Henze; Jochen Schuhmacher; Peter Hipp; J Kowalski; D W Becker; Josef Doll; Helmut R Mäcke; Michael Hofmann; Jürgen Debus; Uwe Haberkorn
PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(7):1053-6.
2001: Uwe Haberkorn; Annette Altmann; Shiming Jiang; I Morr; Miriam Mahmut; Michael Eisenhut
Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene.
European journal of nuclear medicine 2001;28(5):633-8.
2001: Jochen Schuhmacher; S Kaul; G Klivényi; H Junkermann; A Magener; Marcus Henze; Josef Doll; Uwe Haberkorn; Folker Amelung; Gunther Bastert
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
Cancer research 2001;61(9):3712-7.
2001: Uwe Haberkorn; Matthias E Bellemann; Gunnar Brix; Huse Kamencic; I Morr; U Traut; Annette Altmann; Josef Doll; Johannes Blatter; Ralf Kinscherf
Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine.
European journal of nuclear medicine 2001;28(4):418-25.
2001: Uwe Haberkorn; Marcus Henze; Annette Altmann; Shiming Jiang; I Morr; Miriam Mahmut; Peter Peschke; Wolfgang Kübler; Jürgen Debus; Michael Eisenhut
Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(2):317-25.
2001: Gunnar Brix; Marcus Henze; Michael V Knopp; Robert Lucht; Josef Doll; H Junkermann; Hans Hawighorst; Uwe Haberkorn
Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience.
European radiology 2001;11(10):2058-70.
2001: Uwe Haberkorn
Gene therapy with sodium/iodide symporter in hepatocarcinoma.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2001;109(1):60-2.
2000: Walter Mier; Ramon Eritja; Ashour Mohammed; Uwe Haberkorn; Michael Eisenhut
Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.
Bioconjugate chemistry 2000;11(6):855-60.
2000: Michael Eisenhut; William E Hull; Ashour Mohammed; Walter Mier; Dorothee Lay; Wilhelm W Just; Karin Gorgas; Wolf D Lehmann; Uwe Haberkorn
Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Journal of medicinal chemistry 2000;43(21):3913-22.
2000: Gunnar Brix; Marcus Henze; Josef Doll; Robert Lucht; J Zaers; H Trojan; Michael V Knopp; Uwe Haberkorn
[Diagnostic evaluation of the breast using PET: optimization of data acquisition and postprocessing].
Nuklearmedizin. Nuclear medicine 2000;39(3):62-6.
1999: G Brix; Matthias E Bellemann; Uwe Haberkorn
Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1999;42(5):936-43.
1999: J Kissel; Ruediger E Port; J Zaers; Matthias E Bellemann; Ludwig G. Strauss; Uwe Haberkorn; Gunnar Brix
Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach.
Medical physics 1999;26(4):609-15.
1999: Gunnar Brix; Matthias E Bellemann; L Gerlach; Uwe Haberkorn
Direct detection of intratumoral 5-fluorouracil trapping using metabolic 19F MR imaging.
Magnetic resonance imaging 1999;17(1):151-5.
1998: Gunnar Brix; Matthias E Bellemann; L Gerlach; Uwe Haberkorn
Intra- and extracellular fluorouracil uptake: assessment with contrast-enhanced metabolic F-19 MR imaging.
Radiology 1998;209(1):259-67.
1998: C Germann; Anthony F Shields; John R Grierson; I Morr; Uwe Haberkorn
5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(8):1418-23.
1998: Uwe Haberkorn; Matthias E Bellemann; L Gerlach; I Morr; H Trojan; Gunnar Brix; Annette Altmann; Josef Doll; Gerhard van Kaick
Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase.
Gene therapy 1998;5(7):880-7.
1998: Uwe Haberkorn; Khashayarsha Khazaie; I Morr; Annette Altmann; M Müller; Gerhard van Kaick
Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase.
Nuclear medicine and biology 1998;25(4):367-73.
1998: Uwe Haberkorn; B Krems; L Gerlach; Peter Bachert; I Morr; M Wiessler; Gerhard van Kaick
Assessment of glucosylifosfamide mustard biodistribution in rats with prostate adenocarcinomas by means of in vivo 31P NMR and in vitro uptake experiments.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1998;39(5):754-61.
1998: Josef Doll; J Zaers; H Trojan; Matthias E Bellemann; Lars-Eric Adam; Uwe Haberkorn; Gunnar Brix
[Optimization of PET image quality by means of 3D data acquisition and iterative image reconstruction].
Nuklearmedizin. Nuclear medicine 1998;37(2):62-7.
1997: Gunnar Brix; J Zaers; Lars-Eric Adam; Matthias E Bellemann; H Ostertag; H Trojan; Uwe Haberkorn; Josef Doll; Franz Oberdorfer; W J Lorenz
Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1614-23.
1997: J Kissel; Gunnar Brix; Matthias E Bellemann; Ludwig G. Strauss; Antonia Dimitrakopoulou-Strauss; Ruediger E Port; Uwe Haberkorn; W J Lorenz
Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.
Cancer research 1997;57(16):3415-23.
1997: Uwe Haberkorn; Matthias E Bellemann; Annette Altmann; L Gerlach; I Morr; Franz Oberdorfer; Gunnar Brix; Josef Doll; Johannes Blatter; Gerhard van Kaick
PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1215-21.
1997: Uwe Haberkorn; Annette Altmann; I Morr; C Germann; Franz Oberdorfer; Gerhard van Kaick
Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(7):1048-54.
1997: Gunnar Brix; Josef Doll; Matthias E Bellemann; H Trojan; Uwe Haberkorn; P Schmidlin; H Ostertag
Use of scanner characteristics in iterative image reconstruction for high-resolution positron emission tomography studies of small animals.
European journal of nuclear medicine 1997;24(7):779-86.
1997: Uwe Haberkorn; Matthias E Bellemann
[Positron emission tomography].
Medizinische Monatsschrift für Pharmazeuten 1997;20(5):117-25.
1997: Uwe Haberkorn; Annette Altmann; I Morr; K W Knopf; C Germann; R Haeckel; Franz Oberdorfer; Gerhard van Kaick
Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(2):287-94.
1996: Gunnar Brix; Matthias E Bellemann; Uwe Haberkorn; L Gerlach; W J Lorenz
Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
Nuclear medicine and biology 1996;23(7):897-906.
1996: C Prenant; A Theobald; Uwe Haberkorn; Matthias E Bellemann; K Weber; Franz Oberdorfer
Feasibility of labeled alpha-acetamido-aminoisobutyric acid as new tracer compound for kinetic labeling of neutral amino acid transport: preparation of alpha-(N-[1-11C]acetyl)- and alpha-(N-[1-14C]acetyl)-aminoisobutyric acid.
Nuclear medicine and biology 1996;23(3):359-63.
1996: S I Ziegler; Uwe Haberkorn; H Byrne; C Tong; S Kaja; J A Richolt; H Byrne; C Tong; R Schosser; H Krieter; S Kaja; J A Richolt; A A Lammertsma; P Price
Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description.
European journal of nuclear medicine 1996;23(2):169-77.
1996: Helmut Schaider; Uwe Haberkorn; Martin R Berger; Franz Oberdorfer; I Morr; Gerhard van Kaick
Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.
European journal of nuclear medicine 1996;23(1):55-60.
1996: S Rowley; M Lindauer; Johannes Gebert; Uwe Haberkorn; Franz Oberdorfer; U Moebius; Christian Herfarth; Hans K Schackert
Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer.
Journal of surgical oncology 1996;61(1):42-8.
1996: Uwe Haberkorn; Franz Oberdorfer; Johannes Gebert; I Morr; K Haack; K Weber; M Lindauer; Gerhard van Kaick; Hans K Schackert
Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):87-94.
1995: Helmut Schaider; Uwe Haberkorn; M Stöhr; Martin R Berger
Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro.
Anticancer research 1995;15(6B):2501-9.
1995: Gunnar Brix; Matthias E Bellemann; Uwe Haberkorn; L Gerlach; Peter Bachert; W J Lorenz
Mapping the biodistribution and catabolism of 5-fluorouracil in tumor-bearing rats by chemical-shift selective 19F MR imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1995;34(3):302-7.
1995: Peter Bannasch; N I Khoshkhou; Hans Hacker; S Radaeva; M Mrozek; U Zillmann; Annette Kopp-Schneider; Uwe Haberkorn; M Elgas; T Tolle
Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks.
Cancer research 1995;55(15):3318-30.
1995: Christoph Reisser; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss; Eberhard Seifert; Ludwig G. Strauss
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Archives of otolaryngology--head & neck surgery 1995;121(3):272-6.
1995: Helmut Schaider; Uwe Haberkorn; Edgar Petru; Martin R Berger
Combination treatment based on metabolic effects of dinaline.
Journal of cancer research and clinical oncology 1995;121(4):203-10.
1994: Uwe Haberkorn; I Morr; Franz Oberdorfer; Matthias E Bellemann; J Blatter; Annette Altmann; B Kahn; Gerhard van Kaick
Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(11):1842-50.
1994: Christoph Reisser; A J Tasman; Uwe Haberkorn; Ludwig G. Strauss
[Differential diagnosis of neck swelling due to suspected metastasis using positron emission tomography].
Laryngo- rhino- otologie 1994;73(10):523-6.
1994: Uwe Haberkorn; Franz Oberdorfer; T Klenner; Ludwig G. Strauss; M Stöhr; R Wallich; Annette Altmann; G V Kaick
Metabolic and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs.
Nuclear medicine and biology 1994;21(6):835-45.
1994: Uwe Haberkorn; S I Ziegler; Franz Oberdorfer; H Trojan; D Haag; Peter Peschke; Martin R Berger; Annette Altmann; Gerhard van Kaick
FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.
Nuclear medicine and biology 1994;21(6):827-34.
1993: Uwe Haberkorn; G Layer; Volker Rudat; Ivan Zuna; A Lorenz; Gerhard van Kaick
Ultrasound image properties influenced by abdominal wall thickness and composition.
Journal of clinical ultrasound : JCU 1993;21(7):423-9.
1993: Christoph Reisser; Uwe Haberkorn; Ludwig G. Strauss
The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.
The Journal of otolaryngology 1993;22(4):231-8.
1993: A Dimitrakopoulou; Ludwig G. Strauss; John H Clorius; H Ostertag; P Schlag; M Heim; Franz Oberdorfer; F Helus; Uwe Haberkorn; Gerhard van Kaick
Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(7):1075-81.
1993: Uwe Haberkorn; Ludwig G. Strauss; A Dimitrakopoulou; E Seiffert; Franz Oberdorfer; S Ziegler; Christoph Reisser; Josef Doll; F Helus; Gerhard van Kaick
Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(1):12-7.
1992: Uwe Haberkorn; M Reinhardt; Ludwig G. Strauss; Franz Oberdorfer; Martin R Berger; Annette Altmann; R Wallich; A Dimitrakopoulou; Gerhard van Kaick
Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(11):1981-7.
1992: Uwe Haberkorn; Ludwig G. Strauss; Christoph Reisser; Gerhard van Kaick
[Positron emission tomography (PET) in the evaluation of tumor proliferation and follow-up of therapy in ear, nose and throat tumors].
Der Radiologe 1992;32(6):296-301.
1992: Christoph Reisser; Uwe Haberkorn; Ludwig G. Strauss
[Diagnosis of energy metabolism in ENT tumors--a PET study].
HNO 1992;40(6):225-31.
1992: R Engenhart; B N Kimmig; Ludwig G. Strauss; K H Höver; J Romahn; Uwe Haberkorn; Gerhard van Kaick; M Wannenmacher
Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1992;168(4):203-12.
1992: E Seifert; A Schadel; Uwe Haberkorn; Ludwig G. Strauss
[Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
HNO 1992;40(3):90-3.
1991: Uwe Haberkorn; Volker Rudat; G Layer; Ivan Zuna; A Lorenz; Gerhard van Kaick
[Influence of abdominal wall composition and thickness on ultrasound B scan].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1991;155(4):327-31.
1991: Uwe Haberkorn; Ludwig G. Strauss; Christoph Reisser; D Haag; A Dimitrakopoulou; S Ziegler; Franz Oberdorfer; Volker Rudat; Gerhard van Kaick
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(8):1548-55.
1991: Uwe Haberkorn; Ludwig G. Strauss; A Dimitrakopoulou; R Engenhart; Franz Oberdorfer; H Ostertag; J Romahn; Gerhard van Kaick
PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(8):1485-90.
1991: G Layer; Ivan Zuna; A Lorenz; Heide Zerban; Uwe Haberkorn; Peter Bannasch; Gerhard van Kaick; U Räth
Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: correlation with histopathology and tissue composition.
Journal of clinical ultrasound : JCU 1991;19(4):193-201.
1991: Christoph Reisser; Uwe Haberkorn; Ludwig G. Strauss
[PET scan in tumor diagnosis in the head and neck].
Laryngo- rhino- otologie 1991;70(4):214-7.
1990: G Layer; Ivan Zuna; A Lorenz; Heide Zerban; Uwe Haberkorn; Peter Bannasch; Gerhard van Kaick; U Räth
Computerized ultrasound B-scan texture analysis of experimental fatty liver disease: influence of total lipid content and fat deposit distribution.
Ultrasonic imaging 1990;12(3):171-88.
1990: Uwe Haberkorn; Ivan Zuna; A Lorenz; Heide Zerban; G Layer; Gerhard van Kaick; U Räth
Echographic tissue characterization in diffuse parenchymal liver disease: correlation of image structure with histology.
Ultrasonic imaging 1990;12(3):155-70.
1990: G Layer; Friedemann J Gückel; M Marin-Grez; Uwe Haberkorn; S Kunze
[A supratentorial hemangioblastoma].
Der Radiologe 1990;30(5):245-9.
1990: J Görich; S A Beyer-Enke; G Layer; Uwe Haberkorn; Gerhard van Kaick
[The significance of different soft tissue density values for the differential diagnosis of mediastinal space-occupying lesions in CT].
Röntgenpraxis; Zeitschrift für radiologische Technik 1990;43(3):88-94.
1989: G Layer; Ivan Zuna; A Lorenz; Uwe Haberkorn; Heide Zerban; Peter Bannasch; Gerhard van Kaick; U Räth
[Computer-assisted ultrasonic B-scan texture analysis of experimental liver tumors].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1989;151(4):443-8.
1989: Uwe Haberkorn; Ivan Zuna; Heide Zerban; G Layer; A Lorenz; Gerhard van Kaick; U Räth
[Quantitative studies on the influence of connective tissue and fatty structures on the ultrasonic image of the liver].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1989;151(4):439-42.